Treatment to Promote Self-regulation in Children With Autism Spectrum Disorder
RecruitingNCT05235919Phase: PHASE2Started 2022-09-22
Summary
This study will evaluate the feasibility of repetitive Transcranial Magnetic Stimulation (rTMS) in Autism Spectrum Disorder (ASD) with self-regulation impairment. Baseline and follow-up participant vi
Eligibility
Sex
ALL
Min Age
9 Years
Max Age
18 Years
Locations
Bloorivew Research InstituteToronto, Ontario, Canada
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05235919